8-A12B/A 1 end_8a12ba.htm 8-A12B/A Blueprint
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 

FORM 8-A/A
(Amendement No.1)
 
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 

ENDRA LIFE SCIENCES INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 (State of incorporation or organization)
26-0579295
(I.R.S. Employer Identification No.)
 
3600 Green Court, Suite 350
Ann Arbor, MI
48105
(Address of principal executive offices)
(Zip Code) 
 
Securities to be registered pursuant to Section 12(b) of the Act:
 
Title of each classto be so registered
 
Name of each exchange on which     each class is to be registered      
  Common Stock, par value $0.0001 per share
 
The NASDAQ Stock Market LLC
 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  ☑ 
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ☐
Securities Act registration statement file number to which this form relates: 333-214724.
 

Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of class)
 

 
 
 
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant’s Securities to be Registered.
The securities to be registered hereby are shares of common stock, par value $0.0001 per share (“Common Stock”), and warrants to purchase shares of Common Stock (the “Warrants”) of ENDRA Life Sciences Inc. (the “Registrant”). The description of the Common Stock and Warrants required by this Item is contained in the Registrant’s Registration Statement on Form S-1 (Registration No. 333-214724) initially filed with the Securities and Exchange Commission on November 21, 2016, and as subsequently amended (the “Registration Statement”), under the caption “Description of the Securities We Are Offering,” and is incorporated herein by reference. The description of the Common Stock and Warrants included in any form of prospectus subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, that constitutes a part of the Registration Statement shall also be deemed to be incorporated herein by reference.
 
Item 2. Exhibits.
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
 
 
 
 
 
 
 
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized, in the City of Ann Arbor, State of Michigan, on this 19th day of December, 2016.
 
ENDRA LIFE SCIENCES INC.
 
 
 
 
 
Date: December 19, 2016
By:  
/s/ Francois Michelon
 
 
 
Name:  Francois Michelon
 
 
 
Title:  Chief Executive Officer and Director